If Race doesn't do a licensing agreement for AML , what would you reckon their strategy would be @IndexInvestor @johndprent
The reason I ask is because @Davisite doesn't seem to be a fan of giving away a lot of the upside and it would be hard to expect BP to put in money for a drug that is still few months away from being clinic ready.
My guess is another SPP but with options thrown in . I am happy to support another SPP depends how attractive it will be for me as well as how detailed the strategy will be.
If Race doesn't do a licensing agreement for AML , what would...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.010(0.81%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $381.6K | 320.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 2171 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
-0.010 ( 5.54 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 48407 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |